(Q40216493)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

title

A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Jason S. McLellan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Nicole L Kallewaard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Nancy D Ulbrandt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Catherine Svabek

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Josephine M McAuliffe

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Daniel Wrapp

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Nita K. Patel

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Andy Q Yuan

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

JoAnn A Suzich

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

Susan Palaszynski

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Jing Zhang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Brian Moldt

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Anis Khan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Kimberly E Cook

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Bettina W M Richter

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Patricia C Ryan

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

language of work or name

English

0 references

publication date

1 May 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

Science Translational Medicine

19 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

issue

388

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

The burden of respiratory syncytial virus infection in young children

19 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Bronchiolitis-associated hospitalizations among US children, 1980-1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Increasing burden and risk factors for bronchiolitis-related medical visits in infants enrolled in a state health care insurance plan

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Effects of viral respiratory infections on lung development and childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

The association between respiratory syncytial virus infection and the development of childhood asthma: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Development of a PIV-vectored RSV vaccine: preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Live attenuated versus inactivated influenza vaccine in infants and young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Codon stabilization analysis of the "248" temperature sensitive mutation for increased phenotypic stability of respiratory syncytial virus vaccine candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Paramyxovirus fusion and entry: multiple paths to a common end

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Cross-neutralization of four paramyxoviruses by a human monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn).

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Increasing the affinity of a human IgG1 for the neonatal Fc receptor: biological consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

A novel investigational Fc-modified humanized monoclonal antibody, motavizumab-YTE, has an extended half-life in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Population pharmacokinetics of palivizumab, a humanized anti-respiratory syncytial virus monoclonal antibody, in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Modeling maternal fetal RSV F vaccine induced antibody transfer in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

A neutralizing antibody Fab-influenza haemagglutinin complex with an unprecedented 2:1 stoichiometry: characterization and crystallization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Safety, Tolerability, and Pharmacokinetics of MEDI8897, the Respiratory Syncytial Virus Prefusion F-Targeting Monoclonal Antibody with an Extended Half-Life, in Healthy Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Preclinical development of monoclonal antibodies: considerations for the use of non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Primary respiratory syncytial virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Analysis of respiratory syncytial virus preclinical and clinical variants resistant to neutralization by monoclonal antibodies palivizumab and/or motavizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

How good are my data and what is the resolution?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Phasercrystallographic software

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Coot: model-building tools for molecular graphics

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

PHENIX: building new software for automated crystallographic structure determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Collaboration gets the most out of software

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAJ1928

10.1126/SCITRANSLMED.AAJ1928

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28469033%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference